Black Diamond Therapeutics, Inc. (BDTX)
2.40
-0.16
(-6.25%)
USD |
NASDAQ |
Jan 20, 16:00
2.40
0.00 (0.00%)
After-Hours: 04:51
Black Diamond Therapeutics Research and Development Expense (Annual): 50.97M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Emergent BioSolutions, Inc. | 64.90M |
| Johnson & Johnson | 17.26B |
| Puma Biotechnology, Inc. | 54.94M |
| Oric Pharmaceuticals, Inc. | 114.07M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |